Hepatitis C Virus (HCV) Occult Infection or Occult HCV RNA Detection?

Journal of Infectious Diseases

Volumn 189, Issue 1, 2004, Pages 3-6

  Lerat, Hervé ^a   Hollinger, F Blaine ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; EDITORIAL; FLAVIVIRUS; GENE REPLICATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENCE; MONOCYTE; MORPHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA GENE; SEROCONVERSION;

HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER DISEASES; RNA, VIRAL;

EID: 1642539125     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380203     Document Type: Editorial

References (34)

1. Lindenbach BD, Rice CM. Flaviviridae: the viruses and their replication, In: Knipe DM, Howley PM, Griffin DE, et al., eds. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:991-1041.
2. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001; 33:455-63.
3. Busch MP, Rawal BD, Feibig EW, Operskalski EA, Mosley JW. Dynamics of HCV viremia and seroconversion in transfusion-acquired HCV infections. In: 51st Annual Meeting of the American Association of Blood Banks. Philadelphia, Pennsylvania. October 31-November 4, 1998 Abstracts. Transfusion 1998; 38:72S.
4. Busch MP. Closing the windows on viral transmission by blood transfusion. In: Stramer SL, ed. Blood safety in the new millennium. Bethesda, MD: American Association of Blood Banks, 2001:33-54.
5. Durand F, Danic B, Tardivel R, et al. Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months. Transfus Clin Biol 2000; 7:242-50.
6. Beld M, Penning M, van Putten M, et al. Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 1999; 94:1183-91.
7. Bassett SE, Brasky KM, Lanford RE. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998; 72:2589-99.
8. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001; 34:194-203.
9. Liang TJ, Baruch Y, Ben-Porath E, et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology 1991; 13:1044-51.
10. Castillo I, Pardo M, Bartolome J, et al. Occult hepatitis C virus infection in patients with persistently abnormal liver function tests of unknown etiology. J Infect Dis 2004; 189:7-14 (in this issue).
11. Cuypers HT, Bresters D, Winkel IN, et al. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol 1992; 30:3220-4.
12. Lerat H, Rumin S, Habersetzer F, et al. In vivo tropism of hepattis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype and cell phenotype. Blood 1998; 91:3841-9.
13. Lerat H, Berthillon P, Habersetzer F, et al. Detection of hepatitis C virus RNA in peripheral and medullar hematopoietic cells. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, eds. Viral hepatitis and liver disease. Turin: Edizioni Minerva Medica, 1997:232-6.
14. Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J Med Virol 2001; 65:14-22.
15. Laskus T, Radkowski M, Piasek A, et al. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes. J Infect Dis 2000; 181:442-8.
16. Lerat H, Berby F, Trabaud MA, et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97: 845-51.
17. Zuckerman E, Zuckerman T. Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage. Blood Rev 2002; 16:119-25.
18. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327:1490-5.
19. Goutagny N, Fatmi A, De Ledinghen V, et al. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 2003; 187:1951-8.
20. Persidsky Y. Model systems for studies of leukocyte migration across the blood-brain barrier. J Neurovirol 1999; 5:579-90.
21. Radkowski M, Wilkinson J, Nowicki M, et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76:600-8.
22. Bolay H, Soylemezoglu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalocyelitis with rigidity. Clin Neurol Neurosurg 1996; 98:305-8.
23. Maggi F, Giorgi M, Fornai C, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol 1999; 5:319-23.
24. Morsica G, Bernardi MT, Novati R, Uberti Foppa C, Castagna A, Lazzarin A. Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients. J Med Virol 1997; 53:252-4.
25. Lanford RE, Chavez D, Chisari FV, Sureau C. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J Virol 1995; 69:8079-83.
26. Zheng X, Pang M, Chan A, Roberto A, Warner D, Yen-Lieberman B. Direct comparison of hepatitis C virus genotypes tested by INNOLiPA HCV II and TRUGENE HCV genotyping methods. J Clin Virol 2003;28:214-6.
27. Madejón A, Manzano ML, Arocena C, Castillo I, Carreño V. Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. J Hepatol 2000; 32:1019-25.
28. Blackberg J, Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000; 33:992-7.
29. Yuki N, Nagoaka T, Yamashiro M, et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003; 37: 1172-9.
30. Rehermann B. Immune responses in hepatitis B virus infection. Semin Liver Dis 2003; 23:21-38.
31. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282:103-7.
32. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted rivers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002; 185:417-21.
33. Schmidt W, Stapleton JT. Whole-blood hepatitis C virus RNA extraction methods. J Clin Microbiol 2001; 39:3812-3.
34. Cook L, Ross AM, Knight GB, Agnello V. Use of whole blood specimens for routine clinical quantification of hepatitis C virus RNA does not increase assay sensitivity. J Clin Microbiol 2000; 38:4326-31.